Global Drug Screening Market; By Product & Services [Equipment (Chromatography Instruments, Immunoassay Analyzers, and Breath Analyzers), Rapid Testing Devices (Oral Fluid Testing Devices and Urine Testing Devices), Consumables (Assay Kits), Laboratory Services, and Accessories (Calibrators & Controls, and Sample Collection Cups) ], By Sample Type [Oral Fluid/Saliva, Breath, Hair, Urine and Other Samples], By End User [Workplace & Schools, Criminal Justice, Hospitals, Drug Testing Laboratories, Personal Users, and Others], By Region [North America, Europe, the Asia-Pacific, the Middle-East & Africa, and Latin America] Trend Analysis, Competitive Market Share & Forecast, 2017-2027
- Published Date: June 2021
- Report ID: BWC20387
- Available Format: PDF
- Page: 156
Report Overview
Drug screening is a diagnostic test used to examine biological samples such as blood, hair, and urine to detect the presence of drug abuse or its metabolites in a person’s body. Drug screening tests are used to establish whether a suspected person is or was under the influence of effects of the drug at a certain period. It is used in organizations to monitor their employees and in the sports industry to detect drug abuse in athletes.
Global Drug Screening Market - Industry Trends & Forecast Report 2027
The global Drug Screening Market was worth USD 4.47 Billion in 2020, and it is further projected to reach a valuation of USD 14.14 Billion by 2027, at a CAGR of 18.6% during 2021-2027 (forecast period). The surge in market demand can be attributed to the increased necessity for the execution of rigorous regulations demanding drug and alcohol testing. The possibility of government support in this industry has also resulted in the worldwide drug screening market being promoted. However, the ban on alcohol consumption in some Islamic countries has reduced the demand for drug screening in many regions. The prohibition of drug testing at the workplace is also a restraining factor in further expansion of market growth.
Source: BlueWeave Consulting
Drug Screening Market Overview
Drug screening is a diagnostic test used to examine biological samples such as blood, hair, and urine to detect the presence of drug abuse or its metabolites in a person’s body. Drug screening tests are used to establish whether a suspected person is or was under the influence of effects of the drug at a certain period. It is used in organizations to monitor their employees and in the sports industry to detect drug abuse in athletes. The market's growth can be attributed to its widespread use in the workplace, criminal justice systems, law enforcement agencies, drug treatment clinics, the laboratory sector, and hospitals. For example, companies regulated by the United States Department of Transportation are subject to federal or state drug testing laws. However, the banning of drug testing in many organizations has resulted in a drop in the drug screening market's demand.
Drug Screening Market Trends
Growth Drivers
Concern Over Increasing Alcohol and Drug Consumption Has Created A Demand for The Market.
Global alcohol use and drug abuse have recently surged, which is cause for concern. Around 192 million people are consuming cannabis according to UN World Drug Report 2020. Over the last few years, the rate of opioid misuse mortality has risen by up to 71%. The cost of drug use is equivalent to losing 28 million years of healthy life. These startling figures are comparable to the rate of alcohol consumption. As a result, the number of accidents caused by drunk driving has increased. These alarming numbers are similar to the alcohol consumption rate. This has resulted in a rising incidence of accidents due to drunk driving. According to National Crime Records Bureau, around 12,256 road accidents related to drunk driving occurred in 2019 in India alone. To curb this menace of alcohol and drug abuse, the demand for the drug screening market has increased. Also, governments and agencies of many countries are working towards initiatives to expand this market and regulate their concern.
Market Opportunities Are Rising Due to The Adoption Of Innovative Methods.
The launch of new products and development in drug screening has created immense opportunities for the growth of the global drug screening market. Apart from alcohol and drug testing, it is being applied in clinical and research studies as well. For example, carvedilol was identified as a possible therapy for retinitis pigmentosa through drug screening utilizing zebrafish visual behavior. The incorporation of new technology into various analytical instruments such as spectroscopic devices and inhalers has improved the drug screening market's services. An increase in government financing for drug testing, as well as increased public awareness of its use, has increased market demand around the world. For example, the United States has strict drug-abuse regulations and requires alcohol and drug testing through the Drug-Free Workplace Act.
Restraints
Prohibition of A Drug Screening In Several Organizations
Many countries such as Canada, Colombia, Argentina, Chile, and South Africa consider alcohol and drug testing in the workplace as a violation of employees' privacy. These organizational policies have hindered the growth of the drug screening market by affecting demand. For instance, drug and alcohol testing in the workplace is strictly prohibited in Poland and the Czech Republic. This lack of demand from the largest end-user market, i.e., the workplace, has hampered the growth of the global drug screening market. The prohibition on alcohol consumption in several Islamic nations has also had an impact on market demand. Concerns about the accuracy of breathalyzers have also contributed to the drug screening market's lackluster appeal.
Impact of COVID-19
The coronavirus outbreak has led to the downfall of many markets across the globe. Many industrial, manufacturing, production, and business development institutions were forced to shut down for an extended period of time due to nationwide lockdowns. The nationwide shutdown has had an impact on the availability of products and services to the drug screening business. As a result, the market's growth has slowed significantly. The market's progress was hampered by disruptions in the global supply chain and a supply-demand mismatch. Furthermore, with the healthcare sector's major focus on COVID-related cases, the number of drug and alcohol testing cases has plummeted, affecting demand from various end-use industries.
Drug Screening Market- By Products & Services
Based on products & services, the Drug Screening Market has been categorized into equipment, rapid testing devices, consumables, laboratory services, accessories, and others. For instance, coronavirus fast antigen testing kits became very popular during the pandemic. The rapid testing devices have been further segmented into oral fluid testing devices and urine testing devices. The urine testing devices segment held the largest share in the market in 2020. Also, the oral fluid testing devices segment is expected to contribute the highest market share during the forecast period. Urine testing devices are becoming more popular as a result of the useful services they provide, such as shorter detection times, quick results, non-invasive nature, and low risk of sample tampering.
Drug Screening Market- By End-Users
Based on end-users, the drug screening market has been categorized into workplace & schools, laboratories, criminal justice, hospital, drug testing laboratories, personal users, and others. In 2020, the workplace segment registered the largest market share. Pre-employment, reasonable suspicion, post-accident, return-to-duty, and monthly drug testing are some of the scenarios in which an organization conducts drug testing. The rise in the workplace segment is also due to increased concern over workplace security and performance. Thus, many organizations have made drug screening a mandatory process. For instance, as many as 90% of Fortune 200 companies currently use some kind of drug testing for their employees. However, issues have arisen in the past over how this practice is a violation of employees' privacy.
Drug Screening Market- Regional Insights
Based on region, the drug screening market is categorized into North America, Europe, the Asia-Pacific, Latin America, and the Middle East & Africa. North America dominated the global market with the largest share in 2020. Increased demand for drug screening has resulted from the alarming prevalence of illicit drug consumption in this region. Furthermore, the drug screening business in this region has grown as a result of government support and favorable policies aimed at reducing drug usage. For instance, The Army Substance Abuse Program is an anti-substance abuse program of the U.S. overseen by the Army Centre for Substance Abuse Program.
However, the Asia-Pacific region is expected to exhibit the highest growth in the global drug screening market during the forecast period. China and India have emerged as the highest growing economy for this market. The rising number of drug addicts, coupled with increased awareness of the importance of drug screening, and the development of improved technology for this industry are driving the market growth. According to a National Survey conducted by United Nations Office on Drugs and Crime, it was reported that 732 lakh people in India are users of alcohol and drugs.
Competitive Landscape
The Drug Screening Market is highly competitive and fragmented with international and regional players. The key players dominating the market are LabCorp, Quest Diagnostics, Abbott Rapid Diagnostics, OraSure Technologies, Alfa Scientific Designs, Thermo Fisher Scientific, Dragerwerk AG, Lifeloc Technologies, MPD Inc., Omega Laboratories, Premier Biotech Inc., Psychemedics Corporation, Roche AG, Shimadzu Corporation, Siemens Healthcare, BioMerieux SA, Synergy Health plc., CareHealth America Corporation, Biomedical Diagnostics, Agilent Technologies, and other prominent players. Routine screening initiatives and marketing activities, and programs carried out by some key players, such as Quest Technologies developing a Drug Testing Index, have improved their productivity. These strategies, along with new product launches, collaboration with government & organizations, and awareness campaigns, are adopted by companies to stay competitive in the market.
Recent Developments
-
In June 2021, Amazon.com Inc announced that it supports the federal legalization of marijuana and has decided to drop marijuana-testing requirements for some sections of its workers.
-
In May 2021, Quidel Corporation began selling its non-prescription QuickVue At-Home OTC COVID-19 Test online through Amazon in the United States.
Scope of Report:
|
Attribute |
Details |
|
Years Considered |
Historical data – 2017-2020 |
|
Base Year – 2020 |
|
|
Forecast – 2021 – 2027 |
|
|
Facts Covered |
Revenue in USD XXX Million |
|
Market Coverage |
The U.S., Canada, Germany, the U.K., France, Italy, Spain, Belgium, Netherlands, Russia, Brazil, Mexico, Argentina, Colombia, Japan, South Korea, China, India, Australia, New Zealand, UAE, South Africa, Saudi Arabia, Turkey, Kuwait, Qatar, Nigeria, Kenya, Iran |
|
Product/Service Segmentation |
By-Products & Services, By Sample Type, By End-User, and By Region |
|
Key Players |
Key players in the market include are LabCorp, Quest Diagnostics, Abbott Rapid Diagnostics, OraSure Technologies, Alfa Scientific Designs, Thermo Fisher Scientific, Dragerwerk AG, Lifeloc Technologies, MPD Inc., Omega Laboratories, Premier Biotech Inc., Psychemedics Corporation, Roche AG, Shimadzu Corporation, Siemens Healthcare, BioMerieux SA, Synergy Health plc., CareHealth America Corporation, Biomedical Diagnostics, Agilent Technologies, and other prominent players. |
By Product & Service
-
Equipment
-
Immunoassay Analysers
-
Chromatography Instruments
-
Breath Analyzers
-
Other Devices
-
Rapid Testing Devices
-
Urine Testing Devices
-
Oral Fluid Testing Devices
-
Consumables
-
Assay Kits
-
Laboratory Services
-
Accessories
-
Sample Collection Cups
-
Calibrators and Controls
By Sample Type
-
Oral Fluid or Saliva Sample
-
Breath Sample
-
Hair Sample
-
Urine Sample
-
Others
By End-User
-
Workplace and Schools
-
Criminal Justice System
-
Hospitals
-
Drug Testing Laboratories
-
Personal Users
-
Others
By Region
-
North America
-
Europe
-
The Asia-Pacific
-
Latin America
-
Middle-East & Africa
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Primary & Secondary Research End-use Industry
2.3.2. Secondary Research
2.3.3. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Global Drug Screening Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining End-use Industry of Suppliers
4.3.2. Bargaining End-use Industry of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Intensity of Rivalry
4.4. Recent Development/ Technological Advancement
4.5. Regulatory Insights
5. Global Drug Screening Market Overview
5.1. Market Size & Forecast by Value, 2017-2027
5.1.1. By Value (USD Billion)
5.2. Market Share & Forecast
5.2.1. By Products & Services
5.2.1.1. Equipment
5.2.1.1.1. Immunoassay Analyzers
5.2.1.1.2. Chromatography Instruments
5.2.1.1.3. Breath Analyzers
5.2.1.1.4. Others
5.2.1.2. Rapid Testing Devices
5.2.1.2.1. Urine Testing Devices
5.2.1.2.2. Oral Fluid Testing Devices
5.2.1.2.3. Others
5.2.1.3. Consumables
5.2.1.3.1. Assay Kits
5.2.1.4. Laboratory Services
5.2.1.5. Accessories
5.2.1.5.1. Calibrators and Controls
5.2.1.5.2. Sample Collection Cups
5.2.1.6. Others
5.2.2. By Sample Type
5.2.2.1 Oral Fluid or Saliva
5.2.2.2 Breath
5.2.2.3 Hair
5.2.2.4 Urine
5.2.2.5 Others
5.2.3. By End-user
5.2.3.1. Workplace & Schools
5.2.3.2. Laboratories
5.2.3.3. Criminal Justice
5.2.3.4. Hospitals
5.2.3.5. Drug testing laboratories
5.2.3.6. Personal users
5.2.3.7. Others
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. Asia-Pacific
5.2.4.4. Latin America
5.2.4.5. Middle East and Africa
6. North Drug Screening Market
6.1. Market Size & Forecast by Value, 2017-2027
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By Products & Services
6.2.2. By Sample Type
6.2.3. By End-User
6.2.4. By Country
6.2.4.1. U.S.
6.2.4.2. Canada
7. Europe Drug Screening Market
7.1. Market Size & Forecast by Value, 2017-2027
7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1. By Products & Services
7.2.2. By Sample Type
7.2.3. By End-User
7.2.4. By Country
7.2.4.1. France
7.2.4.2. Germany
7.2.4.3. Italy
7.2.4.4. Spain
7.2.4.5. U.K.
7.2.4.6. The Netherlands
7.2.4.7. Belgium
7.2.4.8. Russia
7.2.4.9. NORDIC Countries
7.2.4.10. Rest of Europe
8. The Asia-Pacific (APAC) Drug Screening Market
8.1. Market Size & Forecast by Value, 2017-2027
8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
8.2.1. By Products & Services
8.2.2. By Sample Type
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. Japan
8.2.4.2. China
8.2.4.3. India
8.2.4.4. South Korea
8.2.4.5. Australia and New Zealand
8.2.4.6. Southeast Asia Countries
8.2.4.7. Rest of APAC
9. Latin America Drug Screening Market
9.1. Market Size & Forecast by Value, 2017-2027
9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1. By Products & Services
9.2.2. By Sample Type
9.2.3. By End-User
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Argentina
9.2.4.3. Mexico
9.2.4.4. Colombia
9.2.4.5. Rest of Latin America
10.The Middle East & Africa (MEA) Drug Screening Market
10.1. Market Size & Forecast by Value, 2017-2027
10.1.1. By Value (USD Billion)
10.2. Market Share & Forecast
10.2.1. By Products & Services
10.2.2. By Sample Type
10.2.3. By End-User
10.2.4. By Country
10.2.4.1. South Africa
10.2.4.2. Saudi Arabia
10.2.4.3. U.A.E.
10.2.4.4. Qatar
10.2.4.5. Kuwait
10.2.4.6. Iran
10.2.4.7. Turkey
10.2.4.8. Rest of MEA
11.Competitive Landscape
11.1. List of Key Players and their Offerings
11.2. Company Market Share Analysis, 2020
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Competitive Benchmarking, By Product Offerings
11.5. Strategic Developments
12.Impact of Covid-19 across Global Drug Screening Market
13.Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
13.1. LabCorp
13.2. Quest Diagnostics
13.3. Abbott Rapid Diagnostics
13.4. OraSure Technologies
13.5. Alfa Scientific Designs
13.6. Thermo Fisher Scientific
13.7. Dragerwerk AG
13.8. Lifeloc Technologies
13.9. MPD Inc.
13.10. Omega Laboratories
13.11. Premier Biotech Inc.
13.12. Psychemedics Corporation
13.13. Roche AG
13.14. Shimadzu Corporation
13.15. Siemens Healthcare
13.16. BioMerieux SA
13.17. Synergy Health plc.
13.18. CareHealth America Corporation
13.19. Biomedical Diagnostics
13.20. Agilent Technologies
13.21. Other Prominent Players.
14.Key Strategic Recommendations
*Financial details of unlisted companies will be available as per data availability in the final deliverable
**The segmentation and the companies are subjected to modifications based on the in-depth secondary for the final deliverable
List of figures
Fig: Global Drug Screening Segmentation
Fig: Global Drug Screening Market Value Chain Analysis
Fig: Company Market Share Analysis, 2020
Fig: Global Drug Screening Market Size, By Value (USD Billion), 2017-2027
Fig: Global Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027
Fig: Global Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027
Fig: Global Drug Screening Market Share (%), By End-User, By Value, 2017-2027
Fig: Global Drug Screening Market Share (%), By Country, By Value, 2017-2027
Fig: North America Drug Screening Market Size, By Value (USD Billion), 2017-2027
Fig: North America Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027
Fig: North America Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027
Fig: North America Drug Screening Market Share (%), By End-User, By Value, 2017-2027
Fig: North America Drug Screening Market Share (%), By Country, By Value, 2017-2027
Fig: Europe Drug Screening Market Size, By Value (USD Billion), 2017-2027
Fig: Europe Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027
Fig: Europe Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027
Fig: Europe Drug Screening Market Share (%), By End-User, By Value, 2017-2027
Fig: Europe Drug Screening Market Share (%), By Country, By Value, 2017-2027
Fig: Asia-Pacific Drug Screening Market Size, By Value (USD Billion), 2017-2027
Fig: Asia-Pacific Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027
Fig: Asia-Pacific Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027
Fig: Asia-Pacific Drug Screening Market Share (%), By End-User, By Value, 2017-2027
Fig: Asia-Pacific Drug Screening Market Share (%), By Country, By Value, 2017-2027
Fig: Latin America Drug Screening Market Size, By Value (USD Billion), 2017-2027
Fig: Latin America Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027
Fig: Latin America Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027
Fig: Latin America Drug Screening Market Share (%), By End-User, By Value, 2017-2027
Fig: Latin America Drug Screening Market Share (%), By Country, By Value, 2017-2027
Fig: Middle East & Africa Drug Screening Market Size, By Value (USD Billion), 2017-2027
Fig: Middle East & Africa Drug Screening Market Share (%), By Products & Services, By Value, 2017-2027
Fig: Middle East & Africa Drug Screening Market Share (%), By Sample Type, By Value, 2017-2027
Fig: Middle East & Africa Drug Screening Market Share (%), By End-User, By Value, 2017-2027
Fig: Middle East & Africa Drug Screening Market Share (%), By Country, By Value, 2017-2027
List of Tables
Table: Global Drug Screening Market Size, By Products & Services, By Value, 2017-2027
Table: Global Drug Screening Market Size, By Sample Type, By Value, 2017-2027
Table: Global Drug Screening Market Size, By End-User, By Value, 2017-2027
Table: Global Drug Screening Market Size, By Region, By Value, 2017-2027
Table: North America Drug Screening Market Size, By Products & Services, By Value, 2017-2027
Table: North America Drug Screening Market Size, By Sample Type, By Value, 2017-2027
Table: North America Drug Screening Market Size, By End-User, By Value, 2017-2027
Table: North America Drug Screening Market Size, By Country, By Value, 2017-2027
Table: Europe Drug Screening Market Size, By Products & Services, By Value, 2017-2027
Table: Europe Drug Screening Market Size, By Sample Type, By Value, 2017-2027
Table: Europe Drug Screening Market Size, By End-User, By Value, 2017-2027
Table: Europe Drug Screening Market Size, By Country, By Value, 2017-2027
Table: Asia-Pacific Drug Screening Market Size, By Products & Services, By Value, 2017-2027
Table: Asia-Pacific Drug Screening Market Size, By Sample Type, By Value, 2017-2027
Table: Asia-Pacific Drug Screening Market Size, By End-User, By Value, 2017-2027
Table: Asia-Pacific Drug Screening Market Size, By Country, By Value, 2017-2027
Table: Latin America Drug Screening Market Size, By Products & Services, By Value, 2017-2027
Table: Latin America Drug Screening Market Size, By Sample Type, By Value, 2017-2027
Table: Latin America Drug Screening Market Size, By End-User, By Value, 2017-2027
Table: Latin America Drug Screening Market Size, By Country, By Value, 2017-2027
Table: Middle East & Africa Drug Screening Market Size, By Products & Services, By Value, 2017-2027
Table: Middle East & Africa Drug Screening Market Size, By Sample Type, By Value, 2017-2027
Table: Middle East & Africa Drug Screening Market Size, By End-User, By Value, 2017-2027
Table: Middle East & Africa Drug Screening Market Size, By Country, By Value, 2017-2027
Table: LabCorp Financial Analysis
Table: LabCorp Business Overview
Table: Quest Diagnostics Financial Analysis
Table: Quest Diagnostics Business Overview
Table: Abbott Rapid Diagnostics Financial Analysis
Table: Abbott Rapid Diagnostics Business Overview
Table: OraSure Technologies Financial Analysis
Table: OraSure Technologies Business Overview
Table: Alfa Scientific Designs Financial Analysis
Table: Alfa Scientific Designs Business Overview
Table: Thermo Fisher Scientific Financial Analysis
Table: Thermo Fisher Scientific Business Overview
Table: Dragerwerk AG Financial Analysis
Table: Dragerwerk AG Business Overview
Table: Lifeloc Technologies Financial Analysis
Table: Lifeloc Technologies Business Overview
Table: MPD Inc.Financial Analysis
Table: MPD Inc.Business Overview
Table: Omega LaboratoriesFinancial Analysis
Table: Omega LaboratoriesBusiness Overview
Table: Premier Biotech Inc. Financial Analysis
Table: Premier Biotech Inc. Business Overview
Table: Psychemedics Corporation Financial Analysis
Table: Psychemedics Corporation Business Overview
Market Segmentation
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
Frequently Asked Questions (FAQs):
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.